J. Papadiamantis

587 total citations
15 papers, 462 citations indexed

About

J. Papadiamantis is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, J. Papadiamantis has authored 15 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in J. Papadiamantis's work include Estrogen and related hormone effects (9 papers), Cancer, Lipids, and Metabolism (6 papers) and Cancer Risks and Factors (4 papers). J. Papadiamantis is often cited by papers focused on Estrogen and related hormone effects (9 papers), Cancer, Lipids, and Metabolism (6 papers) and Cancer Risks and Factors (4 papers). J. Papadiamantis collaborates with scholars based in Greece, Netherlands and United States. J. Papadiamantis's co-authors include Christos Markopoulos, Helen Gogas, Grigorios Xepapadakis, Stamatis Vassilaros, Klea Katsouyanni, Peter Boyle, D. Trichopoulos, A. Trichopoulou, S Vasilaros and Brian MacMahon and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Breast Cancer Research and Treatment.

In The Last Decade

J. Papadiamantis

15 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Papadiamantis Greece	9	281	188	173	96	69	15	462
Merja B. Marttunen Finland	8	124 0.4×	191 1.0×	54 0.3×	45 0.5×	27 0.4×	9	389
Leilani Morales Belgium	6	222 0.8×	246 1.3×	68 0.4×	27 0.3×	30 0.4×	10	388
Felice Fornaro Italy	11	92 0.3×	163 0.9×	45 0.3×	73 0.8×	133 1.9×	16	443
S. Ashley United Kingdom	4	349 1.2×	316 1.7×	111 0.6×	18 0.2×	32 0.5×	7	527
Nancy Evans United Kingdom	8	95 0.3×	96 0.5×	27 0.2×	163 1.7×	30 0.4×	10	508
HV Thomas United Kingdom	4	240 0.9×	234 1.2×	61 0.4×	69 0.7×	35 0.5×	5	372
Roberto Travaglini Italy	6	245 0.9×	333 1.8×	222 1.3×	12 0.1×	69 1.0×	8	509
SE Hankinson United States	6	74 0.3×	88 0.5×	24 0.1×	72 0.8×	97 1.4×	8	695
U. Omodei Italy	10	79 0.3×	208 1.1×	39 0.2×	24 0.3×	142 2.1×	20	529
S. Day United States	5	101 0.4×	105 0.6×	39 0.2×	27 0.3×	35 0.5×	12	247

Countries citing papers authored by J. Papadiamantis

Since Specialization

Citations

This map shows the geographic impact of J. Papadiamantis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Papadiamantis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Papadiamantis more than expected).

Fields of papers citing papers by J. Papadiamantis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Papadiamantis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Papadiamantis. The network helps show where J. Papadiamantis may publish in the future.

Co-authorship network of co-authors of J. Papadiamantis

This figure shows the co-authorship network connecting the top 25 collaborators of J. Papadiamantis. A scholar is included among the top collaborators of J. Papadiamantis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Papadiamantis. J. Papadiamantis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Markopoulos, Christos, Urania Dafni, Grigorios Xepapadakis, et al.. (2010). Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial. Breast Cancer Research. 12(2). R24–R24. 63 indexed citations

Markopoulos, Christos, Urania Dafni, Dimitrios Koukouras, et al.. (2009). Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy. Breast Cancer Research. 11(3). R35–R35. 31 indexed citations

Markopoulos, Christos, Vasileios Venizelos, Grigorios Xepapadakis, et al.. (2009). Management of bone loss in breast cancer patients: 24-month results from the ARBI trial of anastrozole with risedronate. Journal of Clinical Oncology. 27(15_suppl). 552–552. 2 indexed citations

Markopoulos, Christos, et al.. (2006). Duration of Tamoxifen Effect on Lipidemic Profile of Postmenopausal Breast Cancer Patients following Deprivation of Treatment. Oncology. 70(4). 301–305. 8 indexed citations

Markopoulos, Christos, et al.. (2005). Effect of exemestane on the lipidemic profile of post-menopausal operable breast cancer patients following 5–7 years of adjuvant tamoxifen: preliminary results of the ATENA substudy. Anti-Cancer Drugs. 16(8). 879–883. 29 indexed citations

Markopoulos, Christos, et al.. (2005). The Effect of Exemestane on the Lipidemic Profile of Postmenopausal Early Breast Cancer Patients: Preliminary Results of the TEAM Greek Sub-study. Breast Cancer Research and Treatment. 93(1). 61–66. 54 indexed citations

Papadiamantis, J., et al.. (2004). The effect of exemestane on the lipidemic profile of breast cancer patients: Preliminary results of the TEAM trial Greek sub-study. Journal of Clinical Oncology. 22(14_suppl). 799–799. 2 indexed citations

Markopoulos, Christos, et al.. (2004). The effect of exemestane on the lipidemic profile of breast cancer patients: Preliminary results of the TEAM trial Greek sub-study. Journal of Clinical Oncology. 22(14_suppl). 799–799. 6 indexed citations

Malamos, N., George P. Stathopoulos, Antonios Keramopoulos, J. Papadiamantis, & Stamatis Vassilaros. (1997). Pregnancy and Offspring After the Appearance of Breast Cancer. Obstetrical & Gynecological Survey. 52(7). 402–404. 3 indexed citations

10.

Malamos, N., et al.. (1996). Pregnancy and Offspring after the Appearance of Breast Cancer. Oncology. 53(6). 471–475. 48 indexed citations

11.

Rubens, R.D., Harry Bartelink, E Engelsman, et al.. (1989). Locally advanced breast cancer: The contribution of cytotoxic and endocrine treatment to radiotherapy. European Journal of Cancer and Clinical Oncology. 25(4). 667–678. 73 indexed citations

12.

Katsouyanni, Klea, D. Trichopoulos, Walter C. Willett, et al.. (1988). Risk of breast cancer among greek women in relation to nutrient intake. Cancer. 61(1). 181–185. 99 indexed citations

13.

Adamopoulos, D. A., et al.. (1986). Thyroid disease in patients with benign and malignant mastopathy. Cancer. 57(1). 125–128. 39 indexed citations

14.

Vassilaros, Stamatis, et al.. (1985). Seasonal variations in the frequency distribution of breast cancer in greek women according to the month of their birth. Journal of Cancer Research and Clinical Oncology. 110(1). 79–81. 3 indexed citations

15.

Vassilaros, Stamatis, et al.. (1981). The incidence of positive oestrogen and progesterone receptors in breast cancer of Greek women.. PubMed. 1(4). 195–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact